{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T23:20:20Z","timestamp":1789600820308,"version":"build-2803163510"},"reference-count":23,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2024,9,24]],"date-time":"2024-09-24T00:00:00Z","timestamp":1727136000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Shandong Hengye Biotechnology Co., Ltd"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Vaccines"],"published-print":{"date-parts":[[2024,12,31]]},"DOI":"10.1080\/14760584.2024.2404633","type":"journal-article","created":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T04:38:32Z","timestamp":1726461512000},"page":"958-965","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":1,"title":["Immunogenicity and safety of Vero cell culture-derived Japanese encephalitis vaccine: a phase 3 study in Chinese infants"],"prefix":"10.1080","volume":"23","author":[{"given":"Huanhuan","family":"Wang","sequence":"first","affiliation":[{"name":"Shandong Hengye Biotechnology Co., Ltd","place":["Qingdao, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Wang","sequence":"additional","affiliation":[{"name":"University of Health and Rehabilitation Sciences (Qingdao Municipal Hospital) Pharmacy Department","place":["Qingdao, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shijie","family":"Yan","sequence":"additional","affiliation":[{"name":"Shandong Hengye Biotechnology Co., Ltd","place":["Qingdao, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gengfan","family":"Zhao","sequence":"additional","affiliation":[{"name":"Shandong Hengye Biotechnology Co., Ltd","place":["Qingdao, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanzhen","family":"Wang","sequence":"additional","affiliation":[{"name":"Shandong Hengye Biotechnology Co., Ltd","place":["Qingdao, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Tao","sequence":"additional","affiliation":[{"name":"Jiangsu Provincial Center for Disease Control and Prevention","place":["Nanjing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Xu","sequence":"additional","affiliation":[{"name":"Shandong Hengye Biotechnology Co., Ltd","place":["Qingdao, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinfeng","family":"Wu","sequence":"additional","affiliation":[{"name":"Shandong Hengye Biotechnology Co., Ltd","place":["Qingdao, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2024,9,24]]},"reference":[{"key":"e_1_3_8_3_1","unstructured":"Prevention of Japanese encephalitis in flood areas. [cited 2024 Jun 11]. Available from: https:\/\/www.chinacdc.cn\/jkzt\/crb\/zl\/lxxyxny\/nyzstd\/202008\/t20200829_218744.html"},{"key":"e_1_3_8_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2019.103678"},{"key":"e_1_3_8_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)61753-X"},{"issue":"6","key":"e_1_3_8_6_1","first-page":"362","article-title":"Current situation of clinical epidemiology of Japanese encephalitis in China","volume":"40","author":"Liu N","year":"2019","unstructured":"Liu N, Gao Y, Xie Z, et al. Current situation of clinical epidemiology of Japanese encephalitis in China. Northwest J Def Med. 2019;40(6):362\u2013370. [in Chinese].","journal-title":"Northwest J Def Med"},{"issue":"5","key":"e_1_3_8_7_1","first-page":"486","article-title":"Epidemiological characteristics of Japanese encephalitis in China from 2011 to 2013","volume":"21","author":"Wu D","year":"2015","unstructured":"Wu D, Ning G, Yin Z, et al. Epidemiological characteristics of Japanese encephalitis in China from 2011 to 2013. Chin J Vaccine Immun. 2015;21(5):486\u2013490. [in Chinese].","journal-title":"Chin J Vaccine Immun"},{"key":"e_1_3_8_8_1","doi-asserted-by":"publisher","DOI":"10.4161\/hv.26902"},{"issue":"1","key":"e_1_3_8_9_1","first-page":"1","article-title":"Epidemiology of Japanese encephalitis in China, 2014\u20132018","volume":"26","author":"Wu D","year":"2020","unstructured":"Wu D, Yin Z, Li J, et al. Epidemiology of Japanese encephalitis in China, 2014\u20132018. Chin J Vaccines Immun. 2020;26(1):1\u20134. [in Chinese].","journal-title":"Chin J Vaccines Immun"},{"key":"e_1_3_8_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2006.12.046"},{"key":"e_1_3_8_11_1","unstructured":"Pharmacopoeia of the People\u2019s Republic of China. Instructions for use of lyophilized inactivated Japanese encephalitis vaccine (Vero Cell); 2015."},{"issue":"9","key":"e_1_3_8_12_1","first-page":"1006","article-title":"Immune effect of live attenuated Japanese encephalitis vaccine on virus strains of major circulating genotypes in China","volume":"32","author":"Liu X","year":"2019","unstructured":"Liu X, Lu X, Zhao D, et al. Immune effect of live attenuated Japanese encephalitis vaccine on virus strains of major circulating genotypes in China. Chin J Biol. 2019;32(9):1006\u20131009. [in Chinese].","journal-title":"Chin J Biol"},{"key":"e_1_3_8_13_1","unstructured":"Notice on the issuance of six technical guiding principles including the technical guiding principles for preclinical research of preventive vaccines (Ncpa.Gov.cn). [cited 2024 Jun 5]. Available from: https:\/\/www.nmpa.gov.cn\/xxgk\/fgwj\/gzwj\/gzwjyp\/20051014010101369.html"},{"key":"e_1_3_8_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2012.05.068"},{"key":"e_1_3_8_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2010.04.086"},{"key":"e_1_3_8_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2008.06.050"},{"issue":"1","key":"e_1_3_8_17_1","first-page":"14","article-title":"Cost benefit analysis of Japanese encephalitis vaccination program in Thailand","volume":"28","author":"Siraprapasiri T","year":"1997","unstructured":"Siraprapasiri T, Sawaddiwudhipong W, Rojanasuphot S. Cost benefit analysis of Japanese encephalitis vaccination program in Thailand. Southeast Asian J Trop Med Public Health. 1997;28(1):14\u201318.","journal-title":"Southeast Asian J Trop Med Public Health"},{"key":"e_1_3_8_18_1","doi-asserted-by":"publisher","DOI":"10.1300\/J371v15n01_05"},{"issue":"5","key":"e_1_3_8_19_1","first-page":"334","article-title":"Cost-effectiveness of routine immunization to control Japanese encephalitis in Shanghai, China","volume":"81","author":"Dong D","year":"2003","unstructured":"Dong D, Kilgore PE, Clemens JD, et al. Cost-effectiveness of routine immunization to control Japanese encephalitis in Shanghai, China. Bull World Health Organ. 2003;81(5):334\u2013342.","journal-title":"Bull World Health Organ"},{"key":"e_1_3_8_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2009.10.024"},{"key":"e_1_3_8_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2009.05.034"},{"key":"e_1_3_8_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tmaid.2014.04.011"},{"key":"e_1_3_8_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/jtm.12210"},{"key":"e_1_3_8_24_1","unstructured":"ClinicalTrials.gov [Internet]. Bethesda: United States National Library of medicine (NLM) at the national institutes of Health; 2014 [2024]. Determining long-term safety and efficacy of Japanese encephalitis vaccine when given with measles vaccine. [cited 2024 Jan 5]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00412516?term=Nct00412516&rank=1.06-05-2024"},{"key":"e_1_3_8_25_1","unstructured":"European Public Assessment Summary Report [Internet]. Amsterdam: European Medicines Agency; 2009."}],"container-title":["Expert Review of Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14760584.2024.2404633","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T09:49:11Z","timestamp":1759830551000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14760584.2024.2404633"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,24]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,12,31]]}},"alternative-id":["10.1080\/14760584.2024.2404633"],"URL":"https:\/\/doi.org\/10.1080\/14760584.2024.2404633","relation":{},"ISSN":["1476-0584","1744-8395"],"issn-type":[{"value":"1476-0584","type":"print"},{"value":"1744-8395","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,24]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierv20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierv20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2024-03-07","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-09-11","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-09-24","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}